Norbudrine (INNTooltip International Nonproprietary Name; developmental code name RD-9338), also known as norbutrine (BANTooltip British Approved Name) or as N-cyclobutylnoradrenaline, is a drug of the phenethylamine and catecholamine families described as a sympathomimetic and bronchodilator which was never marketed.[1][2][3] It is the N-cyclobutyl analogue of norepinephrine (noradrenaline).[1][4] The drug was first described in the literature by 1966.[1]

Norbudrine
Clinical data
Other namesNorbutrine; RD-9338; N-Cyclobutylnoradrenaline; N-Cyclobutylnorepinephrine
Drug classSympathomimetic; Bronchodilator
Identifiers
  • 4-[2-(cyclobutylamino)-1-hydroxyethyl]benzene-1,2-diol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H17NO3
Molar mass223.272 g·mol−1
3D model (JSmol)
  • C1CC(C1)NCC(C2=CC(=C(C=C2)O)O)O
  • InChI=1S/C12H17NO3/c14-10-5-4-8(6-11(10)15)12(16)7-13-9-2-1-3-9/h4-6,9,12-16H,1-3,7H2
  • Key:OVTZNVCECJYMDW-UHFFFAOYSA-N

References

edit
  1. ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 1-PA215. ISBN 978-1-4757-2085-3. Retrieved 17 October 2024.
  2. ^ List PH, Hörhammer L (2013). Chemikalien und Drogen Teil A: N-Q. Handbuch der Pharmazeutischen Praxis - Vollständige (4.) Neuausgabe (in German). Springer Berlin Heidelberg. pp. 265–266. ISBN 978-3-642-65035-2. Retrieved 17 October 2024.
  3. ^ "-drine sympathomimetics" (PDF). The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2018 (Stem Book 2018). World Health Organization.
  4. ^ "Norbudrine". PubChem. U.S. National Library of Medicine. Retrieved 17 October 2024.